ARE THE OPTIMUM PHARMACEUTICAL PREPARATIONS USED FOR THE SECOND-LINE ERADICATION THERAPY FOR HELICOBACTER PYLORI INFECTION IN JAPAN? - A DISCUSSION FROM A SIMULATION FOR THE AMOUNT OF ANTIBIOTICS IN STOMACH BASED ON THE DATA OF DISSOLUTION STUDIES -
Journal Title: Journal of Basic and Clinical Pharmacy - Year 2010, Vol 1, Issue 4
Abstract
The purpose of this study was to evaluate whether the optimum preparations are used for the second-line eradication therapy for Helicobacter pylori (H. pylori) infection in Japan. In the therapy, commercial tablets, which have 250 mg of amoxicillin(AMX) and 250 mg of metronidazole (MTZ), are used as antibiotics. The evaluation was performed by dissolution tests and simulations for intragastric drug concentrations based on the dissolution data. The dissolution tests were performed using the paddle method of Japanese pharmacopoeia XV. The data obtained were used for the simulation of intragastric drug concentrations. In dissolution studies, the 100% dissolution time (T100%) of AMX from the tablet which was about 20 min was faster than that from AMX alone (about 6 h). T100% of MTZ from the tablet which was about 3 h was later than that from MTZ alone (about 30 min). In simulated intragastric concentrations,the time above minimum inhibitory concentration (MIC) of the AMX tablet was 6.6 h which was shorter than that of AMX (11.4 h). The Cmax of the MTZ tablet was 0.095 mg/ml which was lower than that of MTZ (0.190 mg/ml). However, AMX is a timedependent antibiotic, longer duration above MIC is desirable. On the other hand, MTZ is a concentration-dependent antibiotic, higher Cmax is desirable. In conclusion, the commercial products are found to be not the best, and preparing an AMX pharmaceutical preparation with more sustained release characteristic and a MTZ preparation with more rapid release characteristic are considered to be very advantageous.
Authors and Affiliations
Mai Kubodera, Yoshiharu Machida, Tadakazu Tokumura
Keywords
Related Articles
- EP ID EP129914
- DOI -
- Views 103
- Downloads 0
ANTIULCER ACTIVITY OF ROOTS OF ZAPOTECA PORTORICENSIS (FAM. FABIACEAE)
Background: The roots of Zapoteca portricensis is a common remedy in the treatment gastrointestinal disorders used by tradomedical practitioners in Eastern Nigeria. Aim: This study was aimed at evaluating the possible a...
ANTIDIABETIC EFFECT OF COMBINED AQUEOUS LEAF EXTRACT OF VERNONIA AMYGDALINA AND METFORMIN IN RATS
This study investigated the antidiabetic activity of the various combinations (ratios) of metformin (50 mg/kg) and aqueous extracts of the leaves of Vernonia amygdalina (100 mg/kg). The ratios of Extract to Metformin wer...
CACO-2 CELL LINES IN DRUG DISCOVERY - AN UPDATED PERSPECTIVE
Cell lines are the invitro models used for the drug permeability studies in the preclinical and clinical phases of the drug discovery. Cell line models are simple and quick to use and avoids the usage of animal models fo...
Extensively drug resistant tuberculosis (XDR-TB): A potential threat
Emergence of extensively drug resistant tuberculosis (XDR-TB) has been reported by more than 55 countries. XDR-TB is considered as untreatable and highly fatal disease. In developing countries like India, number of cases...
Antibacterial activity of Momordica charantia (Curcubitaceae) extracts and fractions
Momordica charantia L. belongs to the family Curcubitaceae and it is very common in many Brazilian regions. The plant is a liana with flowers and yellow fruits that present red seeds when are ripe. Popularly known as “me...